Variability in the elimination of mianserin in elderly patients.

Pharmacokinetics

1982 • 3,815 citations

The Pharmacological Basis of Therapeutics

1986 • 2,365 citations

Defective N-oxidation of sparteine in man: A new pharmacogenetic defect

1979 • 647 citations

Genetically Determined Variability in Acetylation and Oxidation Therapeutic Implications

1985 • 197 citations

Polymorphic oxidation of sparteine and debrisoquine: Related pharmacogenetic entities

1982 • 160 citations

Imipramine demethylation and hydroxylation: Impact of the sparteine oxidation phenotype

1986 • 101 citations

Amitriptyline metabolism: Association with debrisoquin hydroxylation in nonsmokers

1986 • 82 citations

Anticholinergic and blood pressure effects of mianserin, amitriptyline and placebo.

1978 • 71 citations

The potential therapeutic role of the enantiomers and metabolites of mianserin.

1983 • 56 citations

Relationship between mianserin plasma levels and antidepressant effect in a double‐blind trial comparing a single night‐time and divided daily dose regimens.

1978 • 49 citations

The pharmacokinetics of mianserin.

1983 • 28 citations

Mianserin and blood dyscrasias.

1983 • 23 citations

Influence of age on mianserin pharmacokinetics

1982 • 22 citations

Possible mechanism for mianserin induced neutropenia associated with saturable elimination kinetics.

1985 • 17 citations

Plasma Concentrations of Mianserin after Single Dose and at Steady-State in Depressed Elderly Patients

1987 • 15 citations

The pharmacokinetics of mianserin in elderly depressed patients

1983 • 13 citations

Absolute bioavailability of mianserin tablets and solution in healthy humans

1985 • 12 citations

Mianserin kinetics in depressed patients

1983 • 11 citations

Mianserin protein binding in serum and plasma from healthy subjects and patients with depression and rheumatoid arthritis

1985 • 4 citations

Plasma Levels of the Antidepressant Drug Mianserin

1980 • 2 citations